A European evidence-based guideline for the prevention of type 2 diabetes.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryA systematic review of real-world diabetes prevention programs: learnings from the last 15 yearsTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionIs genetic testing useful to predict type 2 diabetes?Insulin resistance and environmental pollutants: experimental evidence and future perspectivesDevelopment and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese PopulationFinnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM CohortFeatures of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelinesPhysical inactivity: a risk factor and target for intervention in renal care.Behavior change in a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention content.Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk.Mobile applications for diabetes self-management: status and potential.Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherenceGenetic risk profiling for prediction of type 2 diabetesSystematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions.Obesity and associated lifestyle in a large sample of multi-morbid German primary care attendeesThe flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.Java-based diabetes type 2 prediction tool for better diagnosis.Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention.Leukocyte telomere length in the Finnish Diabetes Prevention Study.Reasons for (non)participating in a telephone-based intervention program for families with overweight childrenWalking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetesStudy protocol: a multi-professional team intervention of physical activity referrals in primary care patients with cardiovascular risk factors--the Dalby lifestyle intervention cohort (DALICO) study.Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery.Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to PracticeEffectiveness of community-wide and individual high-risk strategies to prevent diabetes: a modelling study.Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.Skin autofluorescence based decision tree in detection of impaired glucose tolerance and diabetesParticipants' perceptions of a group based program incorporating hands-on meal preparation and pedometer-based self-monitoring in type 2 diabetesNeighborhood walkability and cardiometabolic risk factors in Australian adults: an observational studyType 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experimentRisk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.Risk assessment tools for identifying individuals at risk of developing type 2 diabetes.Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes?Computational intelligence in early diabetes diagnosis: a review.Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes.Lifestyle counseling for type 2 diabetes risk reduction in Dutch primary care: results of the APHRODITE study after 0.5 and 1.5 yearsImpact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus--a multicenter study of 578 patients from 225 centres.Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study.Psychosocial deprivation in women with gestational diabetes mellitus is associated with poor fetomaternal prognoses: an observational study.
P2860
Q22241786-44FFE94D-316A-44B6-9594-CE356E814985Q26775712-073FC018-8C6C-4F06-806D-35CCFF61C054Q26822066-D3535E51-B509-41F6-9E2F-7F93BAE78F9EQ26859442-66FE42FB-55A8-425D-9FF5-57592A99880FQ27021737-1CE783AF-7944-44E9-8920-CCEE977C898DQ28551276-072D946F-B936-484D-8D40-DE6FD1E00715Q28553524-82B9CFA0-1A51-47B1-BB17-B49215336C36Q28742404-3A2738B3-31DF-4F64-B8EA-235188EECACEQ30238711-64C45064-B459-414A-9CB1-B44B4434C9D6Q30541294-42EBEBDA-9F5B-4E2F-A1C3-9A576825AB83Q30617921-B5DAD239-66C9-4FCC-9823-1520B871F9FEQ33439458-9D3068AA-925D-4E49-97D7-276D09E4FCBDQ33589814-BFD195D4-65A7-4783-9B71-21DDAC73ECF8Q33807014-45316EAF-2871-4A31-A733-FFDD3A10E6B3Q33824231-D1AF9A63-5C57-4EBB-A78D-0C3730C3F648Q33921413-CAAE587A-8963-46F7-90E7-35F82FFA54D5Q34066395-374582A8-5818-4A33-896C-B8558D257207Q34068654-257899B4-D95D-4C11-BAE9-DF0508175165Q34201551-13C2123D-53CD-4809-B231-4B11B4E0E923Q34228543-B15CDF22-AC6B-4DDC-8D73-91F67E1E8ED0Q34235327-9D7BACBE-DA21-4A32-9ED0-B3BC241F751AQ34285191-AE6DD233-037C-4276-8F9F-C6C641AB8146Q34315071-A8A55475-0179-4A27-958D-EA27C3621C25Q34371263-A02A0F5D-438F-4A3F-B21F-9583669863C2Q34459235-E756A567-F78B-481C-BAA1-0D188643EB12Q34544605-35DDE405-CFC5-410A-8A61-E1829C362D73Q34600964-6270B420-A579-4D23-9349-312CED5105B0Q34764344-66517B5C-3483-4CFD-A4EB-3D9D87E33863Q34764612-F548DD1A-4AA4-4834-A7D7-299CAA34B586Q34943615-9B5A56DB-42AA-4047-8034-4C63336AC914Q35056770-E5CC6046-F2E4-473F-866B-529E6880E294Q35087315-96AD892C-F766-4325-8AD4-AFF8D2AFA5C7Q35095114-DF2C7D7B-137F-4E9A-91EE-1FD71CD83CC3Q35103623-A13CCEA1-BF05-4E78-8814-AB9D36420A58Q35127934-62A48162-A010-4B3B-9D9D-4A4C58617B0AQ35151581-58FE9B77-83EE-4E67-AA64-BE694B67508EQ35179858-5FCCA01E-1535-4110-9A4A-4F26CE0529DBQ35179961-7EAFFA74-2662-47C5-A35F-3A803581C3C5Q35179962-C8101829-AC51-4423-B15A-EB134AB38DEFQ35179971-374AA9CB-AE6F-49F9-AC2D-0ACD5907872A
P2860
A European evidence-based guideline for the prevention of type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A European evidence-based guideline for the prevention of type 2 diabetes.
@en
A European evidence-based guideline for the prevention of type 2 diabetes.
@nl
type
label
A European evidence-based guideline for the prevention of type 2 diabetes.
@en
A European evidence-based guideline for the prevention of type 2 diabetes.
@nl
prefLabel
A European evidence-based guideline for the prevention of type 2 diabetes.
@en
A European evidence-based guideline for the prevention of type 2 diabetes.
@nl
P2093
P50
P356
P1476
A European evidence-based guideline for the prevention of type 2 diabetes
@en
P2093
A Gilis-Januszewska
A Rissanen
A Stadlmayr
A Undeutsch
A-M Felton
P356
10.1055/S-0029-1240928
P478
42 Suppl 1
P50
P577
2010-04-13T00:00:00Z